Editorial: Molecular mechanisms and therapeutic targets of cancer metastasis and therapy resistance.
作者信息
Wang Ya-Wen, Chen Xu
机构信息
Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Department of Pathology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
出版信息
Front Oncol. 2025 Mar 5;15:1571403. doi: 10.3389/fonc.2025.1571403. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Molecular mechanisms and therapeutic targets of cancer metastasis and therapy resistance.社论：癌症转移和治疗耐药性的分子机制及治疗靶点
Front Oncol. 2025 Mar 5;15:1571403. doi: 10.3389/fonc.2025.1571403. eCollection 2025.
2
Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.上皮-间质转化、肿瘤微环境与上皮性恶性肿瘤的转移行为
Int J Biochem Mol Biol. 2012;3(2):117-36. Epub 2012 May 18.
3
The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.肿瘤微环境：肿瘤芽生和上皮-间质转化介导的癌症转移中不可替代的要素。
Cell Adh Migr. 2016 Jul 3;10(4):434-46. doi: 10.1080/19336918.2015.1129481. Epub 2016 Jan 8.
4
Intersecting pathways: The role of hybrid E/M cells and circulating tumor cells in cancer metastasis and drug resistance.交叠通路：杂交 E/M 细胞和循环肿瘤细胞在癌症转移和耐药中的作用。
Drug Resist Updat. 2024 Sep;76:101119. doi: 10.1016/j.drup.2024.101119. Epub 2024 Jul 14.
5
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.利用肿瘤微环境：通过调节上皮-间质转化实现靶向癌症治疗
J Hematol Oncol. 2025 Jan 13;18(1):6. doi: 10.1186/s13045-024-01634-6.
6
Emerging role of tumor microenvironment derived exosomes in therapeutic resistance and metastasis through epithelial-to-mesenchymal transition.肿瘤微环境衍生的外泌体通过上皮间质转化在治疗抵抗和转移中的新作用。
Life Sci. 2021 Sep 1;280:119750. doi: 10.1016/j.lfs.2021.119750. Epub 2021 Jun 23.
7
Cell death under epithelial-mesenchymal transition control in prostate cancer therapeutic response.前列腺癌治疗反应中上皮-间质转化控制下的细胞死亡
Int J Urol. 2018 Apr;25(4):318-326. doi: 10.1111/iju.13505. Epub 2018 Jan 17.
8
Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers.解码肿瘤微环境：乳腺癌转移和治疗耐药中的上皮-间质转化调控以及新型免疫检查点阻断剂的影响
Biomed Pharmacother. 2024 Dec;181:117714. doi: 10.1016/j.biopha.2024.117714. Epub 2024 Nov 29.
9
Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial-Mesenchymal Transition.肿瘤相关巨噬细胞与上皮-间质转化对肿瘤转移的转化意义
Front Immunol. 2017 Sep 13;8:1106. doi: 10.3389/fimmu.2017.01106. eCollection 2017.
10
Activating Invasion and Metastasis in Small Cell Lung Cancer: Role of the Tumour Immune Microenvironment and Mechanisms of Vasculogenesis, Epithelial-Mesenchymal Transition, Cell Migration, and Organ Tropism.激活小细胞肺癌的侵袭和转移：肿瘤免疫微环境的作用以及血管生成、上皮-间充质转化、细胞迁移和器官趋向性的机制。
Cancer Rep (Hoboken). 2024 Oct;7(10):e70018. doi: 10.1002/cnr2.70018.
本文引用的文献
1
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.原发性和转移性乳腺癌中的代谢重编程和治疗抵抗。
Mol Cancer. 2024 Nov 21;23(1):261. doi: 10.1186/s12943-024-02165-x.
2
Multi-stage mechanisms of tumor metastasis and therapeutic strategies.肿瘤转移的多阶段机制与治疗策略。
Signal Transduct Target Ther. 2024 Oct 11;9(1):270. doi: 10.1038/s41392-024-01955-5.
3
Regulatory mechanisms of PD-1/PD-L1 in cancers.PD-1/PD-L1 在癌症中的调控机制。
Mol Cancer. 2024 May 18;23(1):108. doi: 10.1186/s12943-024-02023-w.
4
The underlying mechanism and targeted therapy strategy of miRNAs cross-regulating EMT process through multiple signaling pathways in hepatocellular carcinoma.微小RNA通过多种信号通路交叉调控肝细胞癌上皮-间质转化过程的潜在机制及靶向治疗策略
Front Mol Biosci. 2024 Mar 22;11:1378386. doi: 10.3389/fmolb.2024.1378386. eCollection 2024.
5
Matrix metalloproteinases as biomarkers and therapeutic targets in colitis-associated cancer.基质金属蛋白酶作为结肠炎相关癌症的生物标志物和治疗靶点。
Front Oncol. 2024 Jan 15;13:1325095. doi: 10.3389/fonc.2023.1325095. eCollection 2023.
6
Adhesion, metastasis, and inhibition of cancer cells: a comprehensive review.癌细胞的黏附、转移与抑制：全面综述。
Mol Biol Rep. 2024 Jan 22;51(1):165. doi: 10.1007/s11033-023-08920-5.
7
Inhibition of γ-secretase/Notch pathway as a potential therapy for reversing cancer drug resistance.抑制 γ-分泌酶/Notch 通路作为逆转癌症药物耐药性的潜在治疗方法。
Biochem Pharmacol. 2024 Feb;220:115991. doi: 10.1016/j.bcp.2023.115991. Epub 2023 Dec 20.
8
Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies.ROS 调控的癌症化疗耐药性的分子机制及治疗策略。
Biomed Pharmacother. 2023 Sep;165:115036. doi: 10.1016/j.biopha.2023.115036. Epub 2023 Jun 22.
9
Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers.癌症多药耐药相关分子机制的研究进展
Acta Pharm Sin B. 2023 Mar;13(3):982-997. doi: 10.1016/j.apsb.2022.10.002. Epub 2022 Oct 7.
10
Targeting epigenetic regulators to overcome drug resistance in cancers.靶向表观遗传调控因子以克服癌症中的耐药性。
Signal Transduct Target Ther. 2023 Feb 17;8(1):69. doi: 10.1038/s41392-023-01341-7.
Zotero 插件